-+ 0.00%
-+ 0.00%
-+ 0.00%

Barclays Maintains Overweight on Strategy, Raises Price Target to $175

Benzinga·10/09/2026 15:04:29
Listen to the news
Barclays analyst Nik Cremo maintains Strategy (NASDAQ:MSTR) with a Overweight and raises the price target from $160 to $175.